Continuous Renal Replacement Therapy (CRRT) Devices Market Analysis Europe, North America, Asia, Rest of World (ROW) - US, Germany, UK, China, India - Size and Forecast 2024-2028

Continuous Renal Replacement Therapy (CRRT) Devices Market  2024-2028

The Continuous Renal Replacement Therapy (CRRT) Devices Market size is estimated to grow by USD 611.31 million at a CAGR of 8.07% between 2024 and 2028. 

CRRT offers some key clinical advantages over intermittent blood purification techniques such as intermittent hemodialysis (IHD), sustained low-efficiency daily dialysis (SLEDD), and peritoneal dialysis (PD). CRRT provides more hemodynamic stability, allowing for appropriate fluid clearance, faster recovery of renal function, and more efficient removal of small and large metabolites, making it significantly superior to intermittent renal replacement therapy (IRRT). CRRT improves the renal system through the continuous, gentle removal of excess metabolic waste products while returning normal electrolyte and acid-base tolerance. CRRT is associated with higher rates of renal recovery. Potential long-term effects on clinical outcomes for more than three months could not be analyzed and need to be investigated in further studies. Economic analysis indicates that initial CRRT is cost-effective when the costs of long-term dependence on dialysis are considered. The CRRT is more advanced than IRRT, having technical advantages and reduced mortality, thereby driving the market during the forecast period.

What will be the size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Segmentation by Product, End-user and Geography Analysis

Product Analysis

Consumables

The market share growth by the consumables segment will be significant during the forecast period. A CRRT system comprises the machine and its consumables. The basic consumable components in a CRRT system include an artificial semipermeable membrane (also called the dialyzer or filter), an extracorporeal circuit, and therapy fluids such as dialysate and replacement fluids.

Get a glance at the market contribution of various segments Download PDF Sample

The consumables segment was the largest and was valued at USD 701.62 million in 2018. The factors triggering the growth of this segment are the increasing use of hemofilters, fluids, charcoal filters, and other consumables in CRRT. Moreover, the constant, repeat purchases of consumables due to their one-time use add to the revenue in this segment. As the utilization of CRRT continues to grow due to an increasing incidence of acute kidney injury (AKI) and other renal complications, the demand for consumables associated with CRRT is likely to rise. The therapy is commonly used in critical care settings, and the number of critically ill patients may impact the demand for CRRT supplies. The construction and expansion of healthcare facilities, particularly those equipped with critical care units and specialized renal care units, can contribute to an increased demand for CRRT consumables, which in turn will fuel the growth of the market during the forecast period.

End-user Analysis

Hospitals

The hospitals segment is driven by the growing number of surgical operations performed along with the increase in end-stage renal disease (ESRD) cases. As the population ages, the prevalence of chronic diseases and conditions that can lead to renal complications may increase. Further, hospitals with specialized renal units or nephrology departments may experience higher demand for CRRT. These units may attract patients with complex renal conditions requiring advanced renal replacement therapies. The demand for CRRT in hospitals is influenced by factors such as the prevalence of conditions leading to acute kidney injury, advancements in medical technology, and the overall healthcare infrastructure of a region. As medical practices evolve and the incidence of conditions requiring CRRT increases, hospitals remain central in providing this form of renal replacement therapy, which is expected to have a positive impact on the growth of the market during the forecast period.

Dialysis centers

Dialysis centers play a crucial role in the healthcare system, providing essential services for individuals with kidney-related conditions, particularly those with chronic kidney disease (CKD). The importance of dialysis centers lies in their ability to offer renal replacement therapy, helping patients manage and maintain their health in the face of compromised kidney function. Dialysis centers offer different modalities of renal replacement therapy, including hemodialysis and peritoneal dialysis. This flexibility allows patients to choose a treatment option that aligns with their lifestyle, preferences, and medical conditions. The demand for CRRT may rise as there is an increase in the number of patients experiencing acute kidney injury (AKI), which can result from infections or surgeries. Advancements in dialysis technology are improving the efficiency and accessibility of dialysis treatments, potentially influencing demand for CRRT at dialysis centers, which is expected to have a positive impact on the growth of the market during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

Europe is estimated to contribute 32% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. The continuous renal replacement therapy (CRRT) devices market in Europe is mainly driven by the rise in the geriatric population, new product launches, increase in the numbers of people with AKIs, inclination among patients for renal replacement therapies, high awareness of blood purification techniques, and the development of new technologies with regard to CRRT and related devices. Europe is a leader in medical research and innovation, with ongoing studies and clinical trials focused on improving CRRT outcomes, optimizing therapy delivery, and developing novel technologies. Research initiatives drive advancements in CRRT technology and contribute to its growth in the region.

With the incidence of diabetes reaching epidemic proportions in Europe, many patients with diabetes who will require renal replacement therapy (RRT) will pose a great challenge to national health infrastructure, especially in developing countries in Africa, such as Nigeria. The main challenge is the high expense involved in the therapy. However, about the growth of the CRRT devices market in Africa, the number of CRRT machines has increased to three times than in the past. On the other hand, the cost of CRR therapy has only increased by 20%. Such factors are expected to rive the regional market growth during the forecast period. 

Buy Full Report Now

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

Ardia Digital Health Ltd. - The company offers continuous renal replacement therapy for patients that suffer from acute kidney failure, and are in an intensive care unit.

• Astellas Pharma Inc.
• B.Braun SE
• Baxter International Inc.
• CytoSorbents Corp.
• DaVita Inc.,
• DIAMED Medizintechnik GmbH
• ECRI, Fresenius Medical Care AG and Co. KGaA
• Infomed SA
• Medica S.p.A.
• Medical Components Inc.
• Medtronic Plc
• Nikkiso Co. Ltd.
• Nipro Medical Corp.
• SWS Hemodialysis Care Co. Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing the market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, market trends and analysis, and challenges. 

Key Drivers

The rapid increase in the ageing population is notably driving market growth. The aging population of baby boomers creates a huge demand for medical devices such as CRRT. The aging population is prone to obesity, high blood pressure, diabetes, and other chronic diseases, which drive the sales of CRRT equipment. For instance, as per a Centers for Disease Control and Prevention (CDC) report, chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and account for USD 2.7 trillion in annual healthcare costs in the US in 2021. Thus, the increase in the prevalence of chronic diseases is likely to drive the demand for and adoption of advanced CRRT devices.

However, according to the World Health Organization (WHO), by 2030, one in every six persons in the world will be 60 or older. At this time, the proportion of the population aged 60 and up will rise from 1 billion in 2020 to 1.4 billion. By 2050, the global population of persons aged 60 and up will double (2.1 billion). Thus, the significant increase in the ageing population is likely to drive the adoption of such devices, thereby contributing to the growth of the market during the forecast period.

Significant  Trends

Opportunities in emerging markets are an emerging trend shaping market development. Emerging markets such as China, India, and Mexico present significant growth opportunities for the players involved in the CRRT devices market. AKI is relatively widespread in China and is associated with severe mortality and morbidity. Most of the AKI cases in the country were found to be drug-related, and some were induced by the widespread use of Chinese traditional medicines or remedies. Similarly, in India also, the incidence of AKI is increasing every year. This high prevalence of AKI in various emerging markets is expected to propel the demand for CRRT as a treatment option.

In addition, regulatory policies in the Asia region are more adaptive and business-friendly due to less stringent data requirements. This, along with the increasing competition in mature markets, will further trigger CRRT device manufacturers to focus on emerging markets during the forecast period. Thus, wide opportunities for vendors from emerging markets may positively impact the market growth and trends during the forecast period.

Major  Challenges

Limitations of and complications involved in CRRT a significant challenges hindering market growth. offer various challenges and complications. Issues such as vascular access dysfunction, activation of the coagulation system, air embolism, heat loss and hypothermia, fluid balance errors, and immune system activation are some issues that medical and nursing staff face daily while treating patients undergoing CRRT. Rapid changes in fluid balance during CRRT can lead to hemodynamic instability, including hypotension. Anticoagulation is often required during CRRT to prevent clotting in the extracorporeal circuit.

However, this increases the risk of bleeding. Finding a balance between preventing clotting and avoiding bleeding complications is a challenge. These limitations of CRRT may hamper the growth of the market during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market forecasting report includes the adoption lifecycle of the market research and growth, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market analysis and report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.

 Customer Landscape

Market Analyst Overview

 

The market is witnessing significant growth, driven by the rising prevalence of Acute Kidney Injury (AKI), particularly in ICU patients with AKI (acute kidney injury) and instances of sepsis. The clinical advantage of CRRT (Continuous Renal Replacement Therapy) is underscored, positioning it as a crucial intervention. The market boasts participation from well-established key players engaged in technologically advanced initiatives, complemented by supportive government initiatives and endorsements from organizations like the International Society of Nephrology (INR) and regulatory bodies like the FDA (Food and Drug Administration).

However, challenges persist, such as a shortage of trained ICU professionals, prompting a comprehensive ecosystem analysis to enhance operational efficiency. The market extends beyond devices to include the Leukapheresis market, showcasing a diversified range of CRRT products encompassing systems, disposables, and various types like continuous venovenous hemodiafiltration (CVVHDF). The modality caters to both adult and pediatric segments, aligning with the critical need for effective renal care during hospitalization and minimizing AKI risk.

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

•  Product Outlook
  • Consumables
  • Systems

• End-user Outlook
  • Hospitals
  • Dialysis centers

• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of World (ROW)
    • Brazil
    • Argentina 
    • Australia 

Continuous Renal Replacement Therapy Devices Market Scope
Report Coverage	Details
Page number	166
Base year	2023
Historic period	2018-2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 8.07%
Market Growth 2024-2028	USD 611.31 million
Market structure	Fragmented
YoY growth 2023-2024(%)	6.99
Regional analysis	Europe, North America, Asia, and Rest of World (ROW)
Performing market contribution	Europe at 32%
Key countries	US, Germany, UK, China, and India
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	Ardia Digital Health Ltd., Astellas Pharma Inc., B.Braun SE, Baxter International Inc., CytoSorbents Corp., DaVita Inc., DIAMED Medizintechnik GmbH, ECRI, Fresenius Medical Care AG and Co. KGaA, Infomed SA, Medica S.p.A., Medical Components Inc., Medtronic Plc, Nikkiso Co. Ltd., Nipro Medical Corp., SWS Hemodialysis Care Co. Ltd., Toray Industries Inc., Apollo Health and Lifestyle Ltd., Asahi Kasei Corp., and Medites Pharma spol. s.r.o.
Market dynamics	Parent market growth analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Continuous Renal Replacement Therapy Devices Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the between 2024 and 2028
• Precise estimation of the size and its contribution n of the market in focus to the parent market
• Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
• Companies landscape comparing criticality of inputs and factors of differentiation
• Exclusive Matrix on companies position and classification
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the market industry across Europe, North America, Asia, and Rest of World (ROW)
• Thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch